Clinical Research Facility

Coeur D'Alene, Idaho 83814

We've found

3 trials

at this facility

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Status: Enrolling, Phase IV
Updated: 11/2/2015

941

from 91732

Coeur D'Alene, ID

A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)

Status: Enrolling, Phase III
Updated: 12/31/1969

941

from 91732

Coeur D'Alene, ID

Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)

Status: Enrolling, Phase
Updated: 12/31/1969

941

from 91732

Coeur D'Alene, ID

Use our guide to learn which trials are right for you!